Cas:606114-76-5 N-[2-(Cyclopentylamino)-2-oxoethyl]-N-(2,3-dimethylphenyl)-7-meth ylthieno[2,3-b]quinoline-2-carboxamide manufacturer & supplier

Chemical Name:N-[2-(Cyclopentylamino)-2-oxoethyl]-N-(2,3-dimethylphenyl)-7-meth ylthieno[2,3-b]quinoline-2-carboxamide

CAS.NO:606114-76-5

Synonyms:N-[2-(Cyclopentylamino)-2-oxoethyl]-N-(2,3-dimethylphenyl)-7-meth ylthieno[2,3-b]quinoline-2-carboxamide

Molecular Formula:C₂₈H₂₉N₃O₂S

Molecular Weight:471.61400

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:94.03000

Exact Mass:471.19800

LogP:6.92060

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like N-[2-(Cyclopentylamino)-2-oxoethyl]-N-(2,3-dimethylphenyl)-7-meth ylthieno[2,3-b]quinoline-2-carboxamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-[2-(Cyclopentylamino)-2-oxoethyl]-N-(2,3-dimethylphenyl)-7-meth ylthieno[2,3-b]quinoline-2-carboxamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-[2-(Cyclopentylamino)-2-oxoethyl]-N-(2,3-dimethylphenyl)-7-meth ylthieno[2,3-b]quinoline-2-carboxamide Use and application,N-[2-(Cyclopentylamino)-2-oxoethyl]-N-(2,3-dimethylphenyl)-7-meth ylthieno[2,3-b]quinoline-2-carboxamide technical grade,usp/ep/jp grade.

Related News: Biogen research chief Alfred Sandrock said the FDA had painstakingly analyzed its clinical trial data over two years before reaching a conclusion. N-[2-(Cyclopentylamino)-2-oxoethyl]-N-(2,3-dimethylphenyl)-7-meth ylthieno[2,3-b]quinoline-2-carboxamide manufacturer Commonly used generic drugs: the products whose patents have expired and the generic drugs of many companies have participated in the competition, and the market demand is large. N-[2-(Cyclopentylamino)-2-oxoethyl]-N-(2,3-dimethylphenyl)-7-meth ylthieno[2,3-b]quinoline-2-carboxamide supplier Commonly used generic drugs: the products whose patents have expired and the generic drugs of many companies have participated in the competition, and the market demand is large. N-[2-(Cyclopentylamino)-2-oxoethyl]-N-(2,3-dimethylphenyl)-7-meth ylthieno[2,3-b]quinoline-2-carboxamide vendor For both Black and white women, younger age and ER-negative breast cancer were risk factors in the genes most strongly associated with breast cancer, including BRCA1, BRCA2 and PALB2. N-[2-(Cyclopentylamino)-2-oxoethyl]-N-(2,3-dimethylphenyl)-7-meth ylthieno[2,3-b]quinoline-2-carboxamide factory Biogen research chief Alfred Sandrock said the FDA had painstakingly analyzed its clinical trial data over two years before reaching a conclusion.